MeSH D002303 - low cardiac output
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Dobutamine | Dobutamine |  | 1993-10-19 |  |  |
| Dopamine | Dopamine |  | 1991-10-23 |  |  | |
| Sanofi | Inamrinone | Inocor |  | 1984-07-31 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%5/5
Phase 2
33%3/9
Phase 3
69%11/16
Approved: 7Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use